10x Genomics, Inc. Operating Lease, Liability, Noncurrent
10x Genomics, Inc. (TXG) had Operating Lease, Liability, Noncurrent of $66.78 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-07
- 2026-06-30: Operating Lease, Liability, Noncurrent $66.78M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $70.06M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $73.38M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $76.44M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $66.78M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $70.06M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $73.38M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $76.44M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $77.08M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $70.63M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $73.33M 10-K · filed 2026-02-13 |
| 2024-09-30 | $76.46M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $78.66M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $81.05M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $83.85M 10-K · filed 2025-02-13 |
| 2023-09-30 | $88.47M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $90.33M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $92.84M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $86.14M 10-K · filed 2024-02-15 |
| 2022-09-30 | $87.83M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $91.04M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $93.54M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $76.85M 10-K · filed 2023-02-16 |
| 2021-09-30 | $75.73M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $65.92M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $66.34M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $57.04M 10-K · filed 2022-02-18 |
| 2020-09-30 | $56.62M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $55.23M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $56.17M 10-Q · filed 2020-05-12 |
| 2020-01-01 | $50.70M 10-K · filed 2021-02-26 |
| 2019-12-31 | $0.00 10-Q · filed 2020-05-12 |